20412 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer
#1202Method of determining composition effective for treating diabetes
#1203BCKDK inhibitors
#1204sGC STIMULATORS
#1205SHP2 phosphatase inhibitors and methods of making and using the same
#1206COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#1207Stable pharmaceutical compositions of dihydroergotamine mesylate
#1208HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS
#1209THERAPEUTIC COMPOUNDS
#1210Pharmaceutical compositions of nilotinib
#1211HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#1212SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES
#1213Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
#1214NOVEL TRICYCLIC COMPOUNDS
#1215OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
#1216Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
#1217ORGANIC COMPOUNDS
#1218Methods of treating acute depression and/or acute anxiety
#1219COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
#1220TUMOR BIOMARKERS AND USE THEREOF
#1221Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections
#1222USE OF SELECTIVE GABA A ALPHA 5 NEGATIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS
#1223Liquid oral formulations for sildenafil
#1224Use of tadalafil as protein arginine methyltransferase (PRMT5) inhibitor
#1225Combination methods and compositions including sleep therapeutics for treating mood
#1226FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#1227OXADIAZOLYLTHIOPHENE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS
#1228COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA
#1229Combination of an FGFR inhibitor and a CMET inhibitor
#1230Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system
#1231Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
#1232Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of group II metabotropic glutamate receptor
#1233Methods, compositions, and uses of novel FYN kinase inhibitors
#1234Use of gaboxadol in the treatment of diabetes and related conditions
#1235COMBINATIONS FOR TREATING CANCER
#1236BCKDK inhibitors
#1237Oral film formulation for modulating absorption profile
#1238Heterocyclic inhibitors of PTPN11
#1239PANCREATIC ENDOCRINE PROGENITOR CELL THERAPIES FOR THE TREATMENT OF OBESITY AND TYPE 2 DIABETES (T2D)
#1240Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
#1241POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#1242Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect
#1243ORGANIC COMPOUNDS
#1244Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#1245ORGANIC COMPOUNDS
#1246NOVEL METHODS
#1247COMPOSITION REMEDY TO PREVENT SYMPTOMS RELATED TO EXCESSIVE ALCOHOL CONSUMPTION
#1248NOVEL METHODS
#1249NOVEL METHODS
#1250Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
#1251METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS
#1252METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY
#1253Pyrazolo[1,5-a]pyrazin-4-yl derivatives
#1254Therapeutic compounds and uses thereof
#1255Pharmaceutical compositions
#1256Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#1257PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE
#1258Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof
#1259Triaryl compounds for treatment of PD-L1 diseases
#1260THERAPEUTIC AND DIAGNOSTIC METHODS FOR MAST CELL-MEDIATED INFLAMMATORY DISEASES
#1261Transmucosal methods for treating psychiatric and neurological conditions
#1262METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF
#1263Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors
#1264Compositions and methods for regulating glucose homeostasis and insulin action
#1265IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR
#1266Pulmonary hypertension treatment
#1267Compositions and methods to protect mammalian tissue against cold and other metabolic stresses
#1268Methods for Treating HCV
#1269Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#1270Bicyclic and tricyclic compounds
#1271Anti-cancer nuclear hormone receptor-targeting compounds
#1272Inhibitors of human immunodeficiency virus replication
#1273Nanoparticle Compositions and Methods for Synthesis Thereof
#1274Oral compositions and the preparation methods thereof
#1275Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity
#1276Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients
#1277Organic compounds
#1278Therapeutic Compositions
#1279METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#1280Compounds and compositions for inhibition of FASN
#1281Preservative removal from eye drops
#1282COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ERGOT ALKALOID TOXICITY
#1283Type I diabetes therapy
#1284Treatment of tachycardia
#1285Compositions, devices, and methods for treating or preventing headaches
#1286Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of group II metabotropic glutamate receptor
#1287COMPOSITIONS AND METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#1288MODULATORS OF THE INTEGRATED STRESS PATHWAY
#1289Preservative removal from eye drops
#1290Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity
#1291Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-piperidinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dione
#1292Imidazopyrazine inhibitors of Bruton's tyrosine kinase
#1293Methods for Treating HCV
#1294METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES
#1295Drug delivery system
#1296Prognosis method of multiple myeloma
#1297Combination formulation of three antiviral compounds
#1298Compositions and methods for preparing and using mitochondrial uncouplers
#1299FOOD AND BEVERAGE COMPOSITIONS COMPRISING PDE5 INHIBITORS
#1300Cyclic peroxides as prodrugs for selective delivery of agents
#1301Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#1302COMPOUNDS FOR USE IN REGULATING FOLLICLE MATURATION
#1303TLR7/8 ANTAGONISTS AND USES THEREOF
#1304Therapeutic heterocyclic compounds
#1305Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
#1306Low-dose triple combination formulation
#1307Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase
#1308SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE
#1309PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
#13104,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
#1311Annulated glycosidase inhibitors
#1312COMBINATION OF A BTK INHIBITOR AND AN INHIBITOR OR CDK9 TO TREAT CANCER
#1313PHARMACEUTICAL COMPOSITIONS FOR TREATING DIABETES AND PREPARATION METHOD THEREOF
#1314Endoparasitic depsipeptides
#1315INHIBITORS OF JUN N-TERMINAL KINASE
#1316Heterocyclic compounds as pad inhibitors
#1317Bromocriptine formulations
#1318METHOD FOR PRODUCING BEADS
#1319Fused indazole pyridone compounds as antivirals
#1320Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#1321Inhibitors of hepatitis C virus replication
#1322Mitofusin activators and uses thereof
#13236,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
#1324Pharmaceutical compositions of nilotinib
#1325Combination therapy for treating pulmonary hypertension
#1326Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate
#1327Method of treating metabolic disorders and depression with dopamine receptor agonists
#1328Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors
#1329Solid pharmaceutical compositions for treating HCV
#1330APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#1331Hetero-halo inhibitors of histone deacetylase
#1332Organic compounds
#1333Heating unit for use in a drug delivery device
#1334BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
#1335Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#1336MEDICAL APPLICATION OF COMPOSITION OF FRUCTOSE-1,6-BISPHOSPHATE AND BLOOD CONCENTRATION STABILIZER THEREOF
#1337Methods of increasing lacrimal proteins
#1338Sleep improving agent
#1339CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
#1340Inhibitors of protein kinases
#1341Antibacterial compounds
#1342FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS
#1343Treatment of erectile dysfunction and other indications
#1344Extended release compositions of opioid antagonists and phosphodiesterase 5 inhibitors
#1345Methods and materials for treating calcific aortic valve stenosis
#1346Antiviral therapy
#1347LINEAR POLYSACCHARIDE BASED FILM PRODUCTS
#1348Uses of DPP IV inhibitors
#1349NK-3 receptor antagonists for therapeutic treatment of leptin-related disease
#1350SURVIVIN-TARGETING ANTI-TUMOR AGENTS AND USES THEREOF
#1351Methods for Treating HCV
#1352MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE
#1353CANCER TREATMENT AND/OR PREVENTION THROUGH REGULATION OF UBIQUITINATION
#1354SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME
#1355Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
#1356Antiproliferative compounds and second active agents for combined use
#1357Tadalafil orally dissolving film and preparation method thereof
#1358SELF-GELLING SOLUTIONS FOR ADMINISTRATION OF THERAPEUTICS TO THE INNER EAR
#1359BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
#1360Compositions and methods for treatment of erectile disfunction
#1361ENRICHED ALCOHOLIC BEVERAGES
#1362COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#1363CXCR7 inhibitors for the treatment of cancer
#1364ALK5 inhibitors
#1365Use of cannabidiol in treatment of pulmonary hypertension
#1366Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
#1367PYRAZOLE CARBOXAMIDE COMPOUNDS AND METHODS OF USE
#1368INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
#1369Compositions, devices, and methods for treating or preventing headaches
#1370Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
#1371PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF
#1372Compounds and pharmaceutical compositions containing at least one of the compounds
#1373Pharmaceutical compound
#1374METHODS OF INHIBITING FUNGAL CERAMIDE SYNTHASE FOR TREATMENT OF CRYPTOCOCCUS NEOFORMANS INFECTION
#1375THERAPEUTIC REGIMEN
#1376METHODS AND MEDICAL USES
#1377Bicyclic compounds and methods for their use in treating autism
#1378Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
#1379Piperazine heteroaryl derivative, preparation method therefor and use of same in medicine
#1380Regimens for treating HIV infections and AIDS
#1381Theranostic agents
#1382Compositions and methods for treatment of erectile dysfunction
#1383Compositions and methods for treatment of erectile disfunction
#1384Fused heterocyclic compound
#1385Substituted indole Mcl-1 inhibitors
#1386Glucokinase activator compositions for the treatment of diabetes
#1387Combination Drug Therapy
#1388LIVER X RECEPTOR MODULATORS
#1389Sulfonamide derivatives as JAK inhibitors
#1390PECTIN GUMMY COMPOSTION AND METHODS OF MAKING AND USING THEREOF
#1391GELATIN GUMMY COMPOSTION AND METHODS OF MAKING AND USING THEREOF
#1392COMPOSITION FOR TREATING ACUTE URINARY RETENTION
#1393METHODS OF TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES
#1394SUBSTITUTED 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
#1395Treatment of hepatocellular carcinoma characterized by hepatitis B virus infection
#1396Dihydropyrimidine compounds and uses thereof in medicine
#1397METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY
#1398Substituted tetrahydroquinolinone compounds as ROR gamma modulators
#1399Fused tricyclic compounds and uses thereof in medicine
#1400Tablets with improved acceptance and good storage stability
#1401Parenteral unit dosage form of dihydroergotamine
#1402Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h, 7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one and methods of treating conditions of the central nervous system
#1403PDE5 compositions and methods for immunotherapy
#1404Heteroaryl Derivatives as PARP Inhibitors
#1405Treatment of pemphigus
#1406Oral film formulation for modulating absorption profile
#1407METHODS FOR THE DIAGNOSIS AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
#1408Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity
#1409APPLICATION OF 5-HT6 RECEPTOR ANTAGONISTS FOR THE ALLEVIATION OF COGNITIVE DEFICITS OF DOWN SYNDROME
#1410TADALAFIL FREE BASE-CONTAINING FILM DOSAGE FORM CONTAINING POLYETHYLENE GLYCOL-BASED POLYMER AND/OR VINYL PYRROLIDONE-BASED POLYMER AS DISPERSION STABILIZER
#1411Tyrosine amide derivatives as Rho-Kinase inhibitors
#1412Methods using HDAC11 inhibitors
#1413Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
#1414BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#1415HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS
#1416Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
#1417Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
#1418COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#1419Pharmaceutical preparation and method for its manufacture
#1420HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS
#14216-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
#1422Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
#1423COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION
#1424PHARMACEUTICAL FORMULATION CONTAINING TADALAFIL
#1425METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
#1426Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity
#1427INHIBITORS OF BRUTONS TYROSINE KINASE
#1428FUSED HETEROCYCLIC COMPOUNDS AS SELECTIVE BMP INHIBITORS
#1429Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders
#1430Chemokine CXCR4 receptor modulators and uses related thereto
#1431SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
#1432TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
#1433Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#1434TREATMENT OF CANCER WITH SMG1-INHIBITORS
#1435INHIBITORS OF JUN N-TERMINAL KINASE
#1436Therapeutic Compositions
#1437Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors
#1438ENHANCER OF PHOTODYNAMIC EFFECT IN ALA-PDT OR ALA-PDD
#1439Compositions and methods
#1440Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment
#1441Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
#1442Compositions and methods
#1443Compounds and compositions for inhibition of FASN
#1444Method and Compound for Modifying Circadian Clock
#1445COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SCHISTOSOMIASIS
#1446Heteroaryl estrogen receptor modulators and uses thereof
#1447Sulfoximine glycosidase inhibitors
#1448AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS
#1449N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease
#1450METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES
#1451CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY
#1452Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#1453PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
#1454Tumor-treating pharmaceutical composition
#1455Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
#1456Amorphous solid dispersions
#1457Substituted dihydrobenzofuran glycosidase inhibitors
#1458Methods for treating erectile dysfunction with a cGMP-specific phosphodiesterase 5 inhibitor pharmaceutical composition
#1459Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof
#1460BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
#1461Use of a rotifer-derived compound and its analogs for preventing schistosomiasis
#1462Compounds for the treatment of HIV
#1463Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof
#1464Therapeutic Combinations of an Antifolate and a BTK Inhibitor
#1465Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
#1466Soft gelatin capsules containing hydroxypropyl beta cyclodextrin with high stability
#1467Anti-MSR1 antibodies and methods of use thereof
#1468Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
#1469Imidazopyrazine compounds, preparation methods and uses thereof
#1470Antidiabetic heterocyclic compounds
#1471Method of reducing pulmonary exacerbations in respiratory disease patients
#1472Inhibitors of hepatitis C virus
#1473Sublingual films
#1474INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#1475Bicyclic bromodomain inhibitors
#1476Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases
#1477Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof
#1478Fast disintegrating pharmaceutical composition
#1479Bridged bicycloalkyl-substituted aminothiazoles and their methods of use
#1480Particulate materials
#1481Ferroportin inhibitors
#1482Benzimidazoles that enhance the activity of oligonucleotides
#1483KRAS G12C inhibitors and methods of using the same
#1484Bromocriptine formulations
#1485Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma
#1486DIABETES POLYGENIC RISK SCORE
#1487Benzopiperazine compositions as BET bromodomain inhibitors
#1488Compositions and methods of regulating glucose homeostasis and insulin action
#1489ANTIBACTERIAL COMPOUNDS
#1490ANTIBODY-DRUG CONJUGATES AND THERAPEUTIC METHODS USING THE SAME
#1491Methods of treating bipolar disorder
#1492Combination Therapy for Male Sexual Dysfunction
#1493PAC1 receptor agonists (MAXCAPS) and uses thereof
#1494Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof
#1495FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
#1496Compound, and production method thereof, and methods of treatment using the compound
#1497Hepatitis B antiviral agents
#1498Therapeutic combinations using IGF1R pathway inhibitors, and methods to predict anti-IGF1R therapeutic efficacy
#1499Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#1500Processes for the preparation of (3S,4R)-3,ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof